The PMC team is dedicated to promoting the understanding and adoption of personalized medicine concepts, services and products.

Steffan Ho, M.D., Ph.D.

Vice President, Head of Translational Oncology and Oncology Diagnostics, Pfizer

Steffan N. Ho is currently Vice President and Head of Translational Oncology and Oncology Diagnostics in the Global Product Development organization at Pfizer. As a board-certified pathologist and principal research investigator with over 20 years of clinical, academic, and industry experience, Dr. Ho brings together an understanding of clinical diagnostics, human cancer, tumor biology, precision medicine, technology platforms, and drug development. He has contributed to precision oncology efforts supporting the approval of a number of targeted therapies and companion diagnostic tests benefiting patients with solid tumor and hematologic malignancies.